WO2016005743A1 - Analyte concentration measurement - Google Patents

Analyte concentration measurement Download PDF

Info

Publication number
WO2016005743A1
WO2016005743A1 PCT/GB2015/051973 GB2015051973W WO2016005743A1 WO 2016005743 A1 WO2016005743 A1 WO 2016005743A1 GB 2015051973 W GB2015051973 W GB 2015051973W WO 2016005743 A1 WO2016005743 A1 WO 2016005743A1
Authority
WO
WIPO (PCT)
Prior art keywords
potential
cycle
mediator
concentration
test meter
Prior art date
Application number
PCT/GB2015/051973
Other languages
English (en)
French (fr)
Inventor
Zuifang Liu
Original Assignee
Accunostics Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Accunostics Limited filed Critical Accunostics Limited
Priority to CA2953452A priority Critical patent/CA2953452A1/en
Priority to CN201580037065.6A priority patent/CN106687803A/zh
Priority to RU2017103730A priority patent/RU2680266C2/ru
Priority to BR112017000305A priority patent/BR112017000305A2/pt
Priority to AU2015287447A priority patent/AU2015287447A1/en
Priority to KR1020177003207A priority patent/KR20170028408A/ko
Priority to EP15747510.4A priority patent/EP3167282A1/en
Priority to JP2016573879A priority patent/JP6619367B2/ja
Publication of WO2016005743A1 publication Critical patent/WO2016005743A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3274Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration

Definitions

  • the present invention relates to a diffusion based analyte concentration measurement that mitigates the effects of diffusion interfering factors.
  • Electrochemical-based sensors such as self-monitoring blood glucose (SMBG) strips, are used for measuring/determining analyte concentration in fluid samples, for example whole blood.
  • DIF diffusion interfering factors
  • Hct blood haematocrit
  • DIF mitigation can be categorized into active approaches and passive approaches.
  • the former relies on using DIF sensitive signals to have DIF "measurements" which are then used for DIF correction.
  • a problem with active approaches is that they require extra mechanisms, such as additional strip elements, more measurement steps, and additional device/meter components/parts.
  • passive approaches use DIF insensitive signals or signals with negligible DIF effect for the analyte measurement.
  • US8105478B2 describes a method for selecting pulse lengths for measuring the concentration of a redox-active substance as a mediator in a molecular-biological detection system, in which suitable potentials are applied to a working electrode, to cause at least one of an oxidation process and a reduction process, which takes place as a redox reaction.
  • the method comprises pulsing the potential of the working electrode and alternately forming measuring phases and relaxation phases; selecting the measuring-phase pulse lengths so that, towards the end of the pulse, the capacitive current is relatively small in comparison with the Faraday current; and selecting the relaxation-phase pulse lengths so that, towards the end of the pulse, the concentration gradient is relaxed so that at the beginning of a following measuring phase, the change in concentration of the mediator, brought about by the consumption of the mediator by the measurement itself, is reversed to the greatest possible extent approaching the original level.
  • the concentration gradient may gradually and continuously decrease towards the bulk solution.
  • the concentration gradient may fluctuate, whilst generally decreasing towards the bulk solution.
  • the at least one electrode may be coated with at least one redox mediator.
  • the electrode may be in a solution that includes at least one redox mediator, and so is exposed to the at least one redox mediator.
  • the accumulation phase can have a reduction at the working electrode and the measurement phase can have an oxidation at the working electrode.
  • the accumulation phase may have an oxidation and the measurement phase can have a reduction at the working electrode depending on nature of redox reaction involving the analyte and mediator(s). As is known in the art, whether the accumulation phase should have reduction or oxidation depends on the mediator state (oxidised or reduced) before it undergoes the heterogeneous reaction at electrode surface. Also, it will be appreciated that more than one mediator may be used for a series of redox reactions.
  • further potentials may be applied to the electrode(s). Such further potentials could be applied before the first potential or after the second potential.
  • an initiation potential may be applied prior to applying the at least one cycle of pulses, wherein the initiation potential has an open circuit or potential for substantially no redox reaction at the electrodes.
  • the initiation potential may be applied prior to applying each cycle of pulses.
  • the second potential has to immediately follow the first potential, so that the accumulation phase that forces accumulation of the concentration gradient immediately precedes the measurement phase.
  • the second potential is such that after depletion of the established concentration gradient of the mediator another concentration gradient of the mediator builds up (the opposite concentration gradient is established), but with a concentration that increases towards the bulk solution.
  • the magnitudes of the first potential and the second potential may be symmetrical relative to a potential which elicits substantially zero current flow (E 0) .
  • the magnitudes of the first potential and second potential may be asymmetrical to E 0 .
  • Durations of the first potential and the second potential may be the same. Durations of the first potential and the second potential may be different. Durations of the first potential and the second potential may be less than 10 minutes, preferably less than 1 minute, and most preferably less than 5 seconds. Durations of the first potential and the second potential may be between 5 to 100% of the total time of each pulse cycle.
  • a test meter for determining analyte concentration using a redox reaction in an electrochemical cell that has at least two electrodes, one of which is a working electrode, at least one electrode exposed to at least a redox mediator, using at least one cycle of pulses, each cycle having a first potential and a second potential, the meter being configured to: apply a first potential to initiate an accumulation phase that forces accumulation of a concentration gradient of the mediator at or close to the working electrode with a concentration that decreases towards the bulk solution; apply a second potential to initiate a measurement phase and deplete the established concentration gradient of the mediator; and measure current associated with the second potential of each cycle.
  • the test meter is configured to calculate analyte concentration using the measured current.
  • the accumulation phase can be a reduction and the measurement phase can be an oxidation.
  • the accumulation phase can be an oxidation and the measurement phase can be a reduction depending on the nature of the redox reaction involving the analyte and mediator(s). Also, it will be appreciated that more than one mediator may be used for a series of redox reactions.
  • the second potential may be such that after depletion of the established concentration gradient of the mediator another concentration gradient of the mediator builds up, but with a concentration that increases towards the bulk solution.
  • the magnitudes of the first potential and the second potential may be symmetrical relative to a potential that causes substantially zero current flow (E 0 ).
  • the magnitudes of the first potential and second potential may be asymmetrical to E 0 .
  • Durations of the first potential and the second potential may be the same. Durations of the first potential and the second potential may be different. Durations of the first potential and the second potential may be less than 10 minutes, preferably less than 1 minute, and most preferably less than 5 seconds. Durations of the first potential and the second potential may be between 5 to 100% of the total time for each pulse cycle.
  • Figure 1 shows switching redox reactions at two electrodes by controlling potential
  • Figure 2 shows an evolution of M red (reduced mediator) concentration gradient at the working electrode E1 with the redox reaction switch in Figure 1 ;
  • Figure 3 shows a test waveform and a control waveform for applying to the electrodes of an electrochemical cell
  • Figure 4 shows current sensitivity to glucose versus measurement time for various samples taken using the waveforms of Figure 3, where the numbers in the legends are Hct levels as a percentage, and
  • Figure 5 shows the percentage biases to the nominal Hct of current sensitivity to glucose at 0.3 seconds of four of the oxidation pulses of the waveforms of Figure 3, where the numbers in legends are the pulse numbers of the waveforms in Figure 3.
  • This present invention mitigates the effects of DIF current signals by switching and controlling redox reactions at the working and counter electrodes of electrochemical- based sensors that use mediators. This is done by creating a higher concentration of mediator near the working electrode than in the bulk sample during an accumulation phase, so that a mediator concentration gradient is present at the start of each measurement phase.
  • the mediator concentration gradient extends by at least 10nm from the working electrode into the bulk sample.
  • the mediator concentration gradient should not reach the counter electrode, and so ideally the maximum extent of the mediator gradient is less than the separation of the working and counter electrodes. In many practical implementations, it is preferred that by the end of the accumulation phase and the start of the measurement phase, the mediator concentration gradient does not extend to beyond half way between the working and counter electrodes.
  • Figure 1 shows one pulse cycle and the initiated corresponding redox reactions of an electrochemical test strip with two electrodes, a working electrode E1 and a counter electrode E2.
  • the two electrodes are covered with a reagent layer which contains redox mediator (M) and enzyme (Enz).
  • M redox mediator
  • Enz enzyme
  • the working and counter electrodes E1 and E2 respectively are in contact with a whole blood sample and an electrical potential (voltage) is applied between the two electrodes. This results in redox reactions both in the blood (homogeneous redox reactions) and at surfaces of the two electrodes (heterogeneous redox reactions).
  • E red reduction potential
  • E ox oxidation potential
  • E red bias (difference) to E 0 and E ox bias to E 0 can be the same (i.e. symmetrical to E 0 as illustrated in Figure 1 ) or different.
  • oxidized mediator (M ox ) undertakes reduction at the working electrode E1 (reaction 3), whilst reduced mediator (M red ) undertakes oxidation at the counter electrode E2 (reaction 2).
  • glucose (Glue) reacts with M ox involving the enzyme (Enz) to produce M red in blood (reaction 1 ).
  • M red is "accumulated" at the working electrode E1 (both reactions 1 and 3 produce M red ) to a concentration C, higher than the starting M red concentration C 0 and a M red concentration gradient is established with decreasing M red concentration from the working electrode E1 surface towards the bulk solution (see Figure 2A to 2B).
  • the heterogeneous redox reactions at the two electrodes are switched over (see Figure 1 ).
  • glucose concentration is determined by measuring the rate of reaction 5, e.g. by measuring current.
  • Rate of reaction 5 is proportional to M red available at the surface of the working electrode E1 .
  • Reaction 5 proceeds at a sufficiently high rate to cause M red depletion to be faster than its supply (through diffusion) at the surface of the working electrode E1 .
  • M red concentration drops from , through C 0 , ultimately to C zero (see the dotted concentration gradient line in Figure 2C) with time.
  • C g is negative and the rate of reaction 5 decreases with time in a pattern described by the Cottrell equation (see below), and the glucose measurement is Hct dependent.
  • the rate of reaction 5 is dependent on M red diffusion and the M red concentration gradient established during the previous reduction pulse.
  • Increasing Hct decreases M red diffusion, but increases the M red concentration gradient. Therefore, the Hct effect on the glucose measurement is compensated by manipulating the redox reaction switch.
  • the current has to be measured in the concentration gradient depletion phase only, i.e. while the concentration gradient is being depleted. After the depletion phase, when the mediator concentration drops below its start level (i.e. the level prior to the accumulation phase), the current becomes Hct dependent.
  • Establishment of the M red concentration gradient during the accumulation phase can be achieved in various ways, including, but not limited to, controlling the potential magnitude and/or polarity of the pulses applied, controlling the effective surface ratio of the two electrodes, controlling the pulse time, controlling reagent layer components and quantity ratios, or any combination of these.
  • the potential magnitude of the pulses applied is used to force accumulation of the mediator concentration gradient and subsequently deplete the established mediator concentration gradient at the working electrode.
  • other techniques for controlling the accumulation and depletion of mediator concentration are possible.
  • Figure 3 shows a control waveform W69 and test waveform W70.
  • the difference between the test waveform W70 and the control waveform W69 is that the test waveform W70 has a higher potential magnitude for the reduction pulses (pulses 2, 4, 6, 8) than the control waveform W69 to enhance the establishment of M red concentration gradient at the working electrode E1 during these pulses (see Figure 1 ).
  • Both the oxidation and reduction pulses of the test waveform are over-potential. By this it is meant that the potential is of a magnitude that is sufficient for the redox reactions at the electrodes to be dominated by diffusion of the mediator and/or analyte towards the electrode. Magnitudes of the oxidation and reduction pulses are selected and controlled by taking into account the electrochemical properties of the mediator and the electrodes. Both the oxidation and reduction pulses can have positive, negative or zero potentials.
  • Pulse 1 is an initiation pulse that is applied once before the start of the repeated cycles of pulses (i.e. it is not part of the repeated cycle of pulses).
  • Pulse 1 is an under-potential pulse wherein the rate of redox reactions at the electrodes is dominated by the kinetics of the heterogeneous redox reactions to allow hydration/dissolution of the strip reagent layer (potential of this pulse can be E 0 or close to E 0 to keep redox reaction at both the working electrode E1 and the counter electrode E2 to a minimum). Pulse 1 can also be an open circuit.
  • the total test time of the 9 pulses in this experiment was designed for 6.25 seconds, but the test can be completed in 5 seconds (i.e. without pulses 8 and 9) or less.
  • the waveforms were applied to the strip using a potentiostat, so that a positive potential lead to oxidation and a negative/zero potential leads to reduction at the working electrode E1 .
  • the oxidation current i.e. positive pulse current resulting from reaction 5 in Figure 1
  • Techniques for determining glucose concentration using current measured during a redox reaction are well known in the art and so will not be described in detail.
  • FIG. 4 shows that in each graph of W69, there are clear separations between the lines of positive pulses (measuring pulses). Higher Hct corresponds to lower current sensitivity. This indicates that W69 measuring currents are sensitive to Hct variation. In contrast, for the graphs of W70, the line separation disappears or is remarkably decreased, i.e. Hct as a DIF is effectively accounted for. W70 leads to significantly higher current sensitivity than W69, i.e. W70 has enhanced current sensitivity to glucose compared to W69.
  • W70 lines in Figure 4 have higher magnitude than W69 lines; 2) W70 lines of each pulse have similar/close magnitude (they are on top of each other if overlaid) whilst W69 lines of each pulse decreases with time, i.e. W70 retains current sensitivity throughout the test time whilst W69 does not. This is because the established M red concentration gradient during the reduction pulse leads to enhanced reaction 5 of the subsequent oxidation pulse.
  • Figure 5 also show the mitigation of Hct, where percentage bias is the difference in current sensitivity between the Hct of interest and the nominal Hct (defined here as 42%, and so this has zero bias).
  • percentage bias is the difference in current sensitivity between the Hct of interest and the nominal Hct (defined here as 42%, and so this has zero bias).
  • the current sensitivity at 0.3 seconds of the oxidation pulses 3, 5, 7 and 9 are used.
  • the bias to nominal Hct had a range of about 20% to -20% with increased Hct.
  • the bias to nominal Hct was reduced with a range less than +/-10%.
  • DIF mitigation and in particular Hct mitigation
  • Hct mitigation can be achieved by other means. For example, this could be done by increasing the effective surface ratio of the counter electrode E2 to the working electrode E1 , or increasing the duration of the accumulation phase pulses.
  • any technique that forces the accumulation of a concentration gradient of the mediator at the working electrode E1 could be used.
  • the present invention provides a simple and effective technique for mitigating the effects of DIF providing an Hct insensitive measurement.
  • the method could be applied to existing products without making any changes to the strips.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Electrochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
PCT/GB2015/051973 2014-07-08 2015-07-08 Analyte concentration measurement WO2016005743A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CA2953452A CA2953452A1 (en) 2014-07-08 2015-07-08 Analyte concentration measurement
CN201580037065.6A CN106687803A (zh) 2014-07-08 2015-07-08 分析物浓度测量
RU2017103730A RU2680266C2 (ru) 2014-07-08 2015-07-08 Измерение концентрации аналита
BR112017000305A BR112017000305A2 (pt) 2014-07-08 2015-07-08 medição de concentração de analito
AU2015287447A AU2015287447A1 (en) 2014-07-08 2015-07-08 Analyte concentration measurement
KR1020177003207A KR20170028408A (ko) 2014-07-08 2015-07-08 분석물 농도 측정
EP15747510.4A EP3167282A1 (en) 2014-07-08 2015-07-08 Analyte concentration measurement
JP2016573879A JP6619367B2 (ja) 2014-07-08 2015-07-08 検体濃度測定

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1412156.0 2014-07-08
GBGB1412156.0A GB201412156D0 (en) 2014-07-08 2014-07-08 Analyte concentration measurement

Publications (1)

Publication Number Publication Date
WO2016005743A1 true WO2016005743A1 (en) 2016-01-14

Family

ID=51410820

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2015/051973 WO2016005743A1 (en) 2014-07-08 2015-07-08 Analyte concentration measurement

Country Status (10)

Country Link
EP (1) EP3167282A1 (ru)
JP (1) JP6619367B2 (ru)
KR (1) KR20170028408A (ru)
CN (1) CN106687803A (ru)
AU (1) AU2015287447A1 (ru)
BR (1) BR112017000305A2 (ru)
CA (1) CA2953452A1 (ru)
GB (1) GB201412156D0 (ru)
RU (1) RU2680266C2 (ru)
WO (1) WO2016005743A1 (ru)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019070739A1 (en) * 2017-10-03 2019-04-11 Avails Medical, Inc. APPARATUSES, SYSTEMS AND METHODS FOR DETERMINING THE CONCENTRATION OF MICROORGANISMS AND THE SENSITIVITY OF MICROORGANISMS TO ANTI-INFECTIOUS, BASED ON OXIDOREDUCTION REACTIONS
JP2020517928A (ja) * 2017-04-20 2020-06-18 ライフスキャン・スコットランド・リミテッド 分析物測定システムおよび方法
US10883135B2 (en) 2015-08-25 2021-01-05 Avails Medical, Inc. Devices, systems and methods for detecting viable infectious agents in a fluid sample
US11021732B2 (en) 2016-05-31 2021-06-01 Avails Medical, Inc. Devices, systems and methods to detect viable infectious agents in a fluid sample and susceptibility of infectious agents to anti-infectives
US11385200B2 (en) 2017-06-27 2022-07-12 Avails Medical, Inc. Apparatus, systems, and methods for determining susceptibility of microorganisms to anti-infectives

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097860A1 (en) * 2002-05-17 2003-11-27 Oxford Biosensors Limited Analyte measurement
US8105478B2 (en) * 2004-01-29 2012-01-31 Siemens Aktiengesellschaft Method for measuring the concentration or change in concentration of a redox-active substance and corresponding device
US20140027312A1 (en) * 2012-07-24 2014-01-30 Lifescan Scotland Limited System and methods to account for interferents in a glucose biosensor
WO2014202625A1 (en) * 2013-06-18 2014-12-24 Alere Switzerland Gmbh Methods and apparatus for determining analyte in a sample using a sensor having electrodes which are provided with an enzyme and a mediator

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7455975B2 (en) * 2000-04-14 2008-11-25 Esa Biosciences, Inc. Electrochemical detection of nucleic acid sequences
RU2267120C2 (ru) * 2000-07-14 2005-12-27 Лайфскен, Инк. Электрохимический способ измерения скоростей химических реакций
CN103901092B (zh) * 2004-05-14 2016-07-06 拜尔健康护理有限责任公司 检测生物分析物的伏安测量系统
US7749371B2 (en) * 2005-09-30 2010-07-06 Lifescan, Inc. Method and apparatus for rapid electrochemical analysis
ES2397663T3 (es) * 2006-10-05 2013-03-08 Lifescan Scotland Limited Sistemas y procedimientos para determinar una concentración de un analito sustancialmente independiente del hematocrito
US8603768B2 (en) * 2008-01-17 2013-12-10 Lifescan, Inc. System and method for measuring an analyte in a sample
WO2012012341A1 (en) * 2010-07-19 2012-01-26 Cilag Gmbh International System and method for measuring an analyte in a sample
US9005426B2 (en) * 2012-09-28 2015-04-14 Cilag Gmbh International System and method for determining hematocrit insensitive glucose concentration

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097860A1 (en) * 2002-05-17 2003-11-27 Oxford Biosensors Limited Analyte measurement
US8105478B2 (en) * 2004-01-29 2012-01-31 Siemens Aktiengesellschaft Method for measuring the concentration or change in concentration of a redox-active substance and corresponding device
US20140027312A1 (en) * 2012-07-24 2014-01-30 Lifescan Scotland Limited System and methods to account for interferents in a glucose biosensor
WO2014202625A1 (en) * 2013-06-18 2014-12-24 Alere Switzerland Gmbh Methods and apparatus for determining analyte in a sample using a sensor having electrodes which are provided with an enzyme and a mediator

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP3167282A1 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10883135B2 (en) 2015-08-25 2021-01-05 Avails Medical, Inc. Devices, systems and methods for detecting viable infectious agents in a fluid sample
US11021732B2 (en) 2016-05-31 2021-06-01 Avails Medical, Inc. Devices, systems and methods to detect viable infectious agents in a fluid sample and susceptibility of infectious agents to anti-infectives
US11913058B2 (en) 2016-05-31 2024-02-27 Avails Medical, Inc. Devices, systems and methods to detect viable infectious agents in a fluid sample and susceptibility of infectious agents to anti-infectives
JP2020517928A (ja) * 2017-04-20 2020-06-18 ライフスキャン・スコットランド・リミテッド 分析物測定システムおよび方法
US11385200B2 (en) 2017-06-27 2022-07-12 Avails Medical, Inc. Apparatus, systems, and methods for determining susceptibility of microorganisms to anti-infectives
WO2019070739A1 (en) * 2017-10-03 2019-04-11 Avails Medical, Inc. APPARATUSES, SYSTEMS AND METHODS FOR DETERMINING THE CONCENTRATION OF MICROORGANISMS AND THE SENSITIVITY OF MICROORGANISMS TO ANTI-INFECTIOUS, BASED ON OXIDOREDUCTION REACTIONS
US11655494B2 (en) 2017-10-03 2023-05-23 Avails Medical, Inc. Apparatus, systems, and methods for determining the concentration of microorganisms and the susceptibility of microorganisms to anti-infectives based on redox reactions

Also Published As

Publication number Publication date
EP3167282A1 (en) 2017-05-17
CA2953452A1 (en) 2016-01-14
KR20170028408A (ko) 2017-03-13
GB201412156D0 (en) 2014-08-20
RU2017103730A (ru) 2018-08-08
JP2017519990A (ja) 2017-07-20
JP6619367B2 (ja) 2019-12-11
RU2680266C2 (ru) 2019-02-19
AU2015287447A1 (en) 2016-12-22
CN106687803A (zh) 2017-05-17
RU2017103730A3 (ru) 2019-01-14
BR112017000305A2 (pt) 2017-10-31

Similar Documents

Publication Publication Date Title
US10908112B2 (en) Rapid-read gated amperometry devices
RU2262890C2 (ru) Электрохимический способ и устройства, предназначенные для применения при определении концентраций исследуемых веществ с поправкой на гематокритное число
EP3167282A1 (en) Analyte concentration measurement
EP2016399B1 (en) Method for determining underfill in an electrochemical biosensor and underfill detection system
CN106940341B (zh) 用于检测使用过且变干的传感器的系统和方法
RU2647473C2 (ru) Системы и способы для улучшенной стабильности электрохимических сенсеров
JP2008536139A (ja) 電気化学的試験片内の部分的充填の決定
EP3011323B1 (en) Methods and apparatus for determining analyte in a sample using a sensor having electrodes which are provided with an enzyme and a mediator
MX2012014281A (es) Sitema de gestionde llenado insuficiente para un biosensor.
KR20130026528A (ko) 샘플 유체내 피검물의 농도를 결정하는 시스템 및 방법
JP2009535651A5 (ru)
KR101730288B1 (ko) 펄스화된 dc 블록을 갖는 테스트 시퀀스로 분석물질을 전기화학적으로 측정하는 방법들, 및 그것을 통합한 디바이스들, 장치들 및 시스템들
JP2016510124A5 (ru)
EP3213059B1 (en) Method for determining diffusion
CA2811851C (en) Systems and methods of discriminating between a control sample and a test fluid using capacitance
Fujii et al. Detection of direct electron transfer between a redox enzyme and an extended gold-gate using chemical CCD

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15747510

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2016573879

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2015287447

Country of ref document: AU

Date of ref document: 20150708

Kind code of ref document: A

Ref document number: 2953452

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112017000305

Country of ref document: BR

REEP Request for entry into the european phase

Ref document number: 2015747510

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2015747510

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 20177003207

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2017103730

Country of ref document: RU

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 112017000305

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20170106